[Late Breaking Session Pathology and COVID-19 Report]

P Boor1, A Hartmann2

  • 1Institut für Pathologie & Medizinische Klinik II (Nephrologie), Sektion Translationale Nephropathologie, Universitätsklinikum der RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. pboor@ukaachen.de.

Der Pathologe
|December 11, 2020
PubMed

Insights

Pathologists rapidly established an autopsy program for COVID-19 (coronavirus disease 2019), yielding crucial insights into lung, vascular, cardiac, and gastrointestinal pathology. This initiative provided medically significant findings on severe cases.

Area of Science:

  • Pathology
  • Infectious Diseases
  • Cardiology
  • Gastroenterology

Background:

  • The COVID-19 pandemic presented unprecedented challenges to medical understanding.
  • Pathological examination of autopsy material is crucial for understanding disease mechanisms.
  • Early research efforts were vital for informing clinical practice and public health responses.

Purpose of the Study:

  • To summarize key findings presented at the German Society of Pathology's virtual congress on COVID-19 pathology.
  • To highlight the rapid response of German-speaking pathologists to the pandemic.
  • To underscore the medical relevance of early autopsy findings in COVID-19.

Main Methods:

  • Review of lectures from the "Pathology and COVID-19" session at the German Society of Pathology virtual congress.
  • Discussion of data from the German Registry for COVID-19 autopsies (DeRegCOVID).
  • Analysis of SARS-CoV-2 detection methods and pathological findings in various organs.

Main Results:

  • Established German Registry for COVID-19 autopsies (DeRegCOVID) provided significant data.
  • Identified typical lung findings in severe COVID-19 cases.
  • Detailed distinct microvascular changes and cardiac/gastrointestinal involvement in COVID-19 patients.

Conclusions:

  • Pathologists in Germany, Austria, and Switzerland quickly organized an effective autopsy program.
  • The established autopsy program yielded medically highly relevant findings on COVID-19 pathology.
  • Early pathological research significantly contributed to understanding the multifaceted impact of COVID-19.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
655
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
962
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
127
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
640